Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study-Reference-Cited by-同舟云学术

Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study

Published:2011-11-30 Issue:111 Volume:3 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Roychowdhury Sameek¹²,Iyer Matthew K.¹³,Robinson Dan R.¹⁴,Lonigro Robert J.¹³,Wu Yi-Mi¹⁴,Cao Xuhong¹⁴⁵,Kalyana-Sundaram Shanker¹⁴⁶,Sam Lee¹³,Balbin O. Alejandro¹³,Quist Michael J.¹⁴,Barrette Terrence¹⁴,Everett Jessica⁷,Siddiqui Javed¹⁴,Kunju Lakshmi P.¹⁴,Navone Nora⁸,Araujo John C.⁸,Troncoso Patricia⁸,Logothetis Christopher J.⁸,Innis Jeffrey W.⁹,Smith David C.²¹⁰,Lao Christopher D.²¹⁰,Kim Scott Y.¹¹,Roberts J. Scott¹¹¹²,Gruber Stephen B.²¹⁰,Pienta Kenneth J.¹²¹⁰¹³,Talpaz Moshe²¹⁰,Chinnaiyan Arul M.¹³⁴⁵¹³

Affiliation:

1. Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA.

2. Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.

3. Center for Computational Medicine and Biology, University of Michigan, Ann Arbor, MI 48109, USA.

4. Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA.

5. Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA.

6. Department of Environmental Biotechnology, Bharathidasan University, Tiruchirappalli 620024, India.

7. Division of Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.

8. Division of Cancer Medicine, Department of Genitourinary Medical Oncology, M. D. Anderson Cancer Center, Houston, TX 77030, USA.

9. Department of Human Genetics and Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI 48109, USA.

10. Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA.

11. Department of Psychiatry, University of Michigan, Ann Arbor, MI 48109, USA.

12. Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.

13. Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.

Abstract

The mutations present in advanced cancers can be identified by integrative high-throughput sequencing to enable biomarker-driven clinical trials and, ultimately, treatment.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference50 articles.

1. The cancer genome

2. Advances in understanding cancer genomes through second-generation sequencing

3. Comprehensive genomic characterization defines human glioblastoma genes and core pathways

4. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

5. International network of cancer genome projects

Cited by 518 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Squamoid Eccrine Ductal Carcinoma Displays Ultraviolet Mutations and Intermediate Gene Expression Relative to Squamous Cell Carcinoma, Microcystic Adnexal Carcinoma, and Porocarcinoma;Modern Pathology;2024-11

2. Large-scale analysis of whole genome sequencing data from formalin-fixed paraffin-embedded cancer specimens demonstrates preservation of clinical utility;Nature Communications;2024-09-04

3. Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma;World Journal of Gastroenterology;2024-05-28

4. Molecular Tumor Boards: On the evolution of species;European Journal of Cancer;2024-04

5. Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric Oncology;JCO Precision Oncology;2024-03